Search Results 1581-1590 of 16159 for Epilepsy (Partial Onset)

  1. Uveitis Clinical Trials - Mayo Clinic Research

    ... duration than appropriate for a placebo or sham control. Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis Rochester, MN. The ...

  2. Neurosciences - 2018 Archives - Mayo Clinic News Network

    Mayo Clinic Q and A: Deep brain stimulation may reduce seizures caused by epilepsy. Liza Torborg. November 27, 2018. In the Loop: Living with ALS — raising ...

  3. Immunizations Clinical Trials - Mayo Clinic Research

    The purpose of this study is to understand the role of systemic inflammation in the genesis of seizures in susceptible children by gaining a clearer ...

  4. Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer - Mayo Clinic

    Subject has a history of seizures within 12 months of Cycle 1 Day-2 or diagnosed neurological condition placing subject at the increased risk of seizures.

  5. Headache - Overview - Mayo Clinic

    People who seek relief from head and face pain, including migraine, benefit from the expertise of the Department of Neurology specialty group for headache.

  6. A Study to Demonstrate that Acetazolamide is not Inferior to Diazepam for Patients who have Continuous Spike and Wave Brain Pattern in Sleep - Mayo Clinic

    The purpose of this study is to compare the effectiveness of the medications acetazolamide and diazepam for the treatment of patients who have continuous spike ...

  7. A Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Terlipressin Treatment - Mayo Clinic

    ... beginning of plasma volume expansion with albumin. Albumin doses recommended by the IAC are 1 g/kg on the first day (Maximum 100 g) and 20 - 40 g/day ...

  8. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

    Disease duration from symptom onset (defined by first muscle weakness or dysarthria) 12-48 months at the time of visit 1 (baseline);; Able to perform supine ...

  9. Dofetilide (oral route) - Mayo Clinic

    Dofetilide is used to correct irregular heartbeat of patients with atrial fibrillation or atrial flutter to a normal heart rhythm. Dofetilide belongs to the ...

  10. Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study - Mayo Clinic

    No hospitalizations for HIV for at least 4 weeks prior to beginning Visit 1 Screen assessments. ... duration of the study, and no change in dose of PAH ...